Table 5.
Reasons for changing the TB treatment regimen in episodes treated initially with standard or expanded regimens
Reason for regimen change | Initial regimen | Total (%) | |
HRZ* | HRZ ± Eth ± E* | ||
Persistent culture-positive/progressive disease | 10 | 2 | 12 (38) |
Drug resistance | 3 | 4 | 7 (22) |
Adverse event# | 3 | 6 | 9 (28) |
M. bovis BCG/NTM** | 3 | 1 | 4 (12) |
Total (%)## | 19 (59) | 13 (41) | 32 (100) |
*H = isoniazid, R = rifampicin, Z = pyrazinamide, Eth = ethionamide, E = ethambutol,
**M. bovis BCG = Mycobacterium bovis Bacillus Calmette-Guérin disease, NTM = non-tuberculous mycobacteria disease
#In total there were 13 adverse events, only 9 appear in this table as the others did not necessitate a regimen change (2 started on alternative TB regimens, 1 stayed on the initial regimen, 1 had all treatment suspended)
##In total 32 regimen changes were recorded in 29 cases; 3 changed regimens twice